Quantitative Pulmonary Imaging Registry & Biorepository

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Kansas Medical Center

About this trial

The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

The participant is enrolling/has enrolled in a research study at the University of Kansas Medical Center that involves Pulmonary MRI and/or Pulmonary CT.

Disqualifiers

The participant declines to participate.

Trial population

Participating in an Imaging Study at KUMC

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Collect Clinical Data

Collect relevant medical history (including demographic information, diagnoses, medical tests, smoking history), for patients participating in pulmonary imaging research.

Time frame
From Enrollment to 3 Months
2

Establish a Biorepository

Establish a collection of biospecimens from imaging subjects to foster an improved understanding of the physiological significance of imaging biomarkers.

Time frame
From Enrollment to 3 Months
3

Biospecimen Collection

Correlate imaging biomarkers with biospecimens and physiological/vital signs data.

Time frame
From Enrollment to 6 Months
4

Collaborate

Provide images and biospecimens to researchers working to develop analysis methods for pulmonary CT and MRI. Separate IRB approval, alongside appropriate data and/or materials transfer agreements will be needed for these studies.

Time frame
From Enrollment to 12 Months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.